Market Place
Sourcing Support
Virax Biolabs Group Limited Unveils $5M Private Placement
04 Dec 2025 //
PR NEWSWIRE
Virax Biolabs Group Closes $5M Private Placement
04 Dec 2025 //
PR NEWSWIRE
Virax Biolabs CEO Details Clinical Advancements And 2026 Goals
03 Dec 2025 //
PR NEWSWIRE
Virax Biolabs, Emory Partner on ViraxImmune Clinical Studies
26 Aug 2025 //
PR NEWSWIRE
Virax Biolabs Hires Iain as Director for Commercial Strategy
29 Jul 2025 //
PR NEWSWIRE
Virax Biolabs Gets Nasdaq Notice for Minimum Bid Price Deficiency
18 Jul 2025 //
PR NEWSWIRE
Cosmos Signs Deal For Avian Influenza PCR Kits In Middle East
23 Jan 2025 //
ACCESSWIRE
Cosmos Distributes Virax`s Avian Flu PCR Kits In Europe
13 Jan 2025 //
ACCESSWIRE
Virax Biolabs Enters Deal With Europa Biosite For ImmuneSelect
24 Oct 2024 //
PHARMABIZ
Cosmos Health Secures Mpox PCR Kits Distribution Agreement
16 Sep 2024 //
ACCESSWIRE
Virax Biolabs Extends Mpox PCR Kit Distribution With Cosmos Health
16 Sep 2024 //
PR NEWSWIRE
Virax Announces Program Launch of Research Use Only ViraxImmune Product
12 Sep 2023 //
PR NEWSWIRE
Virax Biolabs to initiate Virax Immune Covid-19 Analytical Performance Study
27 Oct 2022 //
PHARMABIZ
Virax Biolabs Announces NASDAQ Closing Bell Ringing for IPO
16 Aug 2022 //
PRESS RELEASE
Why Virax Biolabs Stock Plummeted 74% On Friday
29 Jul 2022 //
FOOL
Virax Biolabs Introduces Monkeypox and VZV Real-Time PCR Detection Kit
26 Jul 2022 //
GLOBENEWSWIRE
Virax Biolabs Group Limited Completes IPO; Shares Begin Trading
21 Jul 2022 //
GLOBENEWSWIRE
Virax Biolabs Group Limited Announces Pricing of $6.75M IPO
20 Jul 2022 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.